U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine

The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca’s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.